22 Healthcare Stocks Moving In Tuesday's Pre-Market Session

Gainers

• Reata Pharmaceuticals, Inc. RETA stock surged 45.2% to $146.07 during Tuesday's pre-market session. The market value of their outstanding shares is at $2.8 billion. The most recent rating by Cantor Fitzgerald, on October 15, is at Overweight, with a price target of $180.00.
• Aphria, Inc. APHA stock increased by 18.6% to $5.16. The market value of their outstanding shares is at $1.8 billion. According to the most recent rating by CIBC, on July 26, the current rating is at Underperformer.
• Zealand Pharma, Inc. ZEAL stock moved upwards by 14.5% to $26.36. The most recent rating by Goldman Sachs, on October 15, is at Buy, with a price target of $41.00.
• Neovasc, Inc. NVCN stock moved upwards by 14.4% to $3.74. The market value of their outstanding shares is at $35.5 million.
• OrganiGram Holdings, Inc. OGI shares surged 11.3% to $3.63. The market value of their outstanding shares is at $808.9 million.
• Valeritas Holdings, Inc. VLRX stock surged 8.7% to $1.38. The market cap seems to be at $10.2 million.
• CannTrust Holdings, Inc. CTST shares rose 8.6% to $1.13. The market value of their outstanding shares is at $223.0 million.
• HEXO, Inc. HEXO shares increased by 6.2% to $2.50. The market cap stands at $1.2 billion. According to the most recent rating by Seaport Global, on October 14, the current rating is at Neutral.
• Immutep, Inc. IMMP stock increased by 5.7% to $1.85.
• Akorn, Inc. AKRX shares moved upwards by 5.3% to $4.00. The market value of their outstanding shares is at $479.3 million. The most recent rating by SunTrust Robinson Humphrey, on September 20, is at Hold, with a price target of $4.00.
• Plus Therapeutics, Inc. PSTV stock rose 4.1% to $2.55. The market value of their outstanding shares is at $1.7 million.
• Tilray, Inc. TLRY stock moved upwards by 3.8% to $21.45. The market cap stands at $2.6 billion. The most recent rating by MKM Partners, on September 20, is at Neutral, with a price target of $34.00.
• Aurora Cannabis, Inc. ACB stock increased by 3.6% to $3.64. The market value of their outstanding shares is at $6.3 billion. The most recent rating by MKM Partners, on September 20, is at Sell, with a price target of $5.00.
• Cronos Group, Inc. CRON shares rose 3.1% to $8.11. The market value of their outstanding shares is at $4.1 billion. The most recent rating by Piper Jaffray, on August 13, is at Overweight, with a price target of $18.00.
• Canopy Growth, Inc. CGC shares moved upwards by 3.0% to $19.40. The market cap stands at $11.0 billion. According to the most recent rating by Seaport Global, on October 14, the current rating is at Neutral.
• Johnson & Johnson, Inc. JNJ shares increased by 2.0% to $133.28. The market cap stands at $347.1 billion. The most recent rating by Raymond James, on October 14, is at Outperform, with a price target of $145.00.
• AAC Holdings, Inc. AAC shares moved upwards by 2.0% to $0.37. The market value of their outstanding shares is at $18.7 million. According to the most recent rating by Raymond James, on August 13, the current rating is at Market Perform.

Losers

• Aclaris Therapeutics, Inc. ACRS stock decreased by 11.3% to $1.25 during Tuesday's pre-market session. The market cap seems to be at $44.6 million. According to the most recent rating by JMP Securities, on September 06, the current rating is at Market Perform.
• Guardion Health Sciences, Inc. GHSI shares fell 8.0% to $0.49. The market value of their outstanding shares is at $28.3 million.
• Advaxis, Inc. ADXS shares decreased by 3.2% to $0.30. The market cap stands at $6.1 million.
• OpGen, Inc. OPGN shares plummeted 2.6% to $7.00. The market value of their outstanding shares is at $6.7 million.
• Ocugen, Inc. OCGN shares plummeted 1.4% to $1.42. The market cap seems to be at $4.4 million.